Patent holdings for IPC class A61K 31/423

Total number of patents in this class: 1551

10-year publication summary

98
111
122
111
102
117
127
105
100
87
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Kowa Company, Ltd.
1196
73
Aldeyra Therapeutics, Inc.
109
33
Takeda Pharmaceutical Company Limited
2696
25
Janssen Pharmaceutica N.V.
3384
22
Boehringer Ingelheim International GmbH
4644
18
F. Hoffmann-La Roche AG
7920
17
Merck Sharp & Dohme LLC
3742
17
J-pharma Co., Ltd.
26
16
Novartis AG
10829
15
The Regents of the University of California
19943
15
Merck Patent GmbH
5818
14
GW Research Limited
193
14
Pfizer Inc.
3380
13
Shionogi & Co., Ltd.
851
13
Bristol-myers Squibb Company
4884
11
Ovid Therapeutics Inc
154
11
Nalpropion Pharmaceuticals LLC
71
11
Jazz Pharmaceuticals Research UK Limited
220
11
Centre National de La Recherche Scientifique
10442
10
Abbott Laboratories
2405
9
Other owners 1183